Media Centre


ACTUALITE DU CIRC

John Cairns (1922 – 2018)

15/11/2018 – The International Agency for Research on Cancer (IARC) was saddened to learn of the passing of Dr John Cairns, who died on 12 November 2018. Dr Cairns was a greatly appreciated collaborator and supporter of IARC over the course of many years. He was a member of the IARC Scientific Council for four years, from 1978, and also served on and chaired the IARC Postdoctoral Fellowship Selection Committee.

Meeting of Advisory Group to Recommend an Update to the Preamble to the IARC Monographs

13/11/2018 – On 12–14 November 2018, the Advisory Group to Recommend an Update to the Preamble to the IARC Monographs is meeting at the International Agency for Research on Cancer (IARC). Scientists with a wide range of expertise have been invited to discuss the Preamble and make recommendations to IARC in an open and transparent way. The Preamble to the IARC Monographs describes the principles and procedures used in developing IARC Monographs, including the scientific criteria that guide the evaluations. The Preamble was last amended in 2006.

New IARC and WHO study estimates how reducing mortality from NCDs could affect longevity

12/11/2018 – A new study by scientists from the International Agency for Research on Cancer (IARC) and the World Health Organization (WHO) estimates how reducing premature mortality from either all noncommunicable diseases (NCDs) or the four major NCDs would affect progress towards achieving United Nations Sustainable Development Goal 3: “Ensure healthy lives and promote well-being for all at all ages”. Goal 3 calls for a reduction of premature mortality from NCDs by one third by 2030 through prevention and treatment and by promoting mental health and well-being. The feasibility of reducing mortality to the targeted level within 15 years was also assessed on the basis of historical mortality trends in 2000–2015.

Cao B, Bray F, Ilbawi A, Soerjomataram I
Effect on longevity of one-third reduction in premature mortality from non-communicable diseases by 2030: a global analysis of the Sustainable Development Goal health target
Lancet Global Health, Published online 9 November 2018;
https://dx.doi.org/10.1016/S2214-109X(18)30411-X

IARC Monographs evaluation of the carcinogenicity of some nitrobenzenes and other industrial chemicals

02/11/2018 – The results of the recent IARC Monographs evaluation of the carcinogenicity of some nitrobenzenes (2-chloronitrobenzene, 4-chloronitrobenzene, 1,4-dichloro-2-nitrobenzene, 2,4-dichloro-1-nitrobenzene, and para-nitroanisole) and other industrial chemicals (2-amino-4-chlorophenol, ortho-phenylenediamine, ortho-phenylenediamine dihydrochloride, and N,N-dimethylacetamide) have now been published in The Lancet Oncology.This summary article presents the conclusions of the IARC Monographs Meeting 123. The evaluations for 2-chloronitrobenzene and 4-chloronitrobenzene were updated since these agents were considered previously in 1995. The remaining agents were evaluated by the Working Group for the first time.
The full scientific assessments will be published as Volume 123 of the IARC Monographs.

IARC Monographs Vol. 123 Group
Lancet Oncol, Published online 2 November 2018;
https://doi.org/10.1016/S1470-2045(18)30823-4

– Voir les autres

CONTACT


Ms Veronique Terrasse, Press Officer.
Tel: +33 4 72 73 83 66
Email: terrassev@iarc.fr

FOLLOW US ON